Literature DB >> 22172593

Neuroendocrine dysfunction in polycystic ovary syndrome.

Christine M Burt Solorzano1, Jennifer P Beller, Michelle Y Abshire, Jessicah S Collins, Christopher R McCartney, John C Marshall.   

Abstract

Polycystic ovarian syndrome (PCOS) is a common disorder characterized by ovulatory dysfunction and hyperandrogenemia (HA). Neuroendocrine abnormalities including increased gonadotropin-releasing hormone (GnRH) pulse frequency, increased luteinizing hormone (LH) pulsatility, and relatively decreased follicle stimulating hormone contribute to its pathogenesis. HA reduces inhibition of GnRH pulse frequency by progesterone, causing rapid LH pulse secretion and increasing ovarian androgen production. The origins of persistently rapid GnRH secretion are unknown but appear to evolve during puberty. Obese girls are at risk for HA and develop increased LH pulse frequency with elevated mean LH by late puberty. However, even early pubertal girls with HA have increased LH pulsatility and enhanced daytime LH pulse secretion, indicating the abnormalities may begin early in puberty. Decreasing sensitivity to progesterone may regulate normal maturation of LH secretion, potentially related to normally increasing levels of testosterone during puberty. This change in sensitivity may become exaggerated in girls with HA. Many girls with HA-especially those with hyperinsulinemia-do not exhibit normal LH pulse sensitivity to progesterone inhibition. Thus, HA may adversely affect LH pulse regulation during pubertal maturation leading to persistent HA and the development of PCOS. Copyright Â
© 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22172593      PMCID: PMC3453528          DOI: 10.1016/j.steroids.2011.12.007

Source DB:  PubMed          Journal:  Steroids        ISSN: 0039-128X            Impact factor:   2.668


  50 in total

1.  Obesity and sex steroid changes across puberty: evidence for marked hyperandrogenemia in pre- and early pubertal obese girls.

Authors:  Christopher R McCartney; Susan K Blank; Kathleen A Prendergast; Sandhya Chhabra; Christine A Eagleson; Kristin D Helm; Richard Yoo; R Jeffrey Chang; Carol M Foster; Sonia Caprio; John C Marshall
Journal:  J Clin Endocrinol Metab       Date:  2006-11-21       Impact factor: 5.958

2.  Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline.

Authors:  Ricardo Azziz; Enrico Carmina; Didier Dewailly; Evanthia Diamanti-Kandarakis; Hector F Escobar-Morreale; Walter Futterweit; Onno E Janssen; Richard S Legro; Robert J Norman; Ann E Taylor; Selma F Witchel
Journal:  J Clin Endocrinol Metab       Date:  2006-08-29       Impact factor: 5.958

Review 3.  Puberty and polycystic ovary syndrome.

Authors:  Selma Feldman Witchel
Journal:  Mol Cell Endocrinol       Date:  2006-06-05       Impact factor: 4.102

4.  Functional significance of polycystic-size ovaries in healthy adolescents.

Authors:  Monica Mortensen; Robert L Rosenfield; Elizabeth Littlejohn
Journal:  J Clin Endocrinol Metab       Date:  2006-08-08       Impact factor: 5.958

5.  Androgens increase gonadotropin-releasing hormone neuron firing activity in females and interfere with progesterone negative feedback.

Authors:  Justyna Pielecka; Samuel D Quaynor; Suzanne M Moenter
Journal:  Endocrinology       Date:  2005-12-08       Impact factor: 4.736

6.  Prevalence of overweight and obesity in the United States, 1999-2004.

Authors:  Cynthia L Ogden; Margaret D Carroll; Lester R Curtin; Margaret A McDowell; Carolyn J Tabak; Katherine M Flegal
Journal:  JAMA       Date:  2006-04-05       Impact factor: 56.272

Review 7.  The origins and sequelae of abnormal neuroendocrine function in polycystic ovary syndrome.

Authors:  S K Blank; C R McCartney; J C Marshall
Journal:  Hum Reprod Update       Date:  2006-05-02       Impact factor: 15.610

Review 8.  Neuroendocrine effects of androgens in adult polycystic ovary syndrome and female puberty.

Authors:  Susan K Blank; Christopher R McCartney; Kristen D Helm; John C Marshall
Journal:  Semin Reprod Med       Date:  2007-09       Impact factor: 1.303

9.  Maturation of luteinizing hormone (gonadotropin-releasing hormone) secretion across puberty: evidence for altered regulation in obese peripubertal girls.

Authors:  Christopher R McCartney; Kathleen A Prendergast; Susan K Blank; Kristin D Helm; Sandhya Chhabra; John C Marshall
Journal:  J Clin Endocrinol Metab       Date:  2008-10-28       Impact factor: 5.958

10.  Metabolic and reproductive features before and during puberty in daughters of women with polycystic ovary syndrome.

Authors:  Teresa Sir-Petermann; Ethel Codner; Virginia Pérez; Bárbara Echiburú; Manuel Maliqueo; Amanda Ladrón de Guevara; Jessica Preisler; Nicolás Crisosto; Fernando Sánchez; Fernando Cassorla; Shalender Bhasin
Journal:  J Clin Endocrinol Metab       Date:  2009-02-17       Impact factor: 5.958

View more
  54 in total

Review 1.  Sex and hormonal influences on seizures and epilepsy.

Authors:  Jana Velíšková; Kara A Desantis
Journal:  Horm Behav       Date:  2012-04-04       Impact factor: 3.587

2.  Progesterone-Mediated Inhibition of the GnRH Pulse Generator: Differential Sensitivity as a Function of Sleep Status.

Authors:  Su Hee Kim; Jessica A Lundgren; Ruchi Bhabhra; Jessicah S Collins; James T Patrie; Christine M Burt Solorzano; John C Marshall; Christopher R McCartney
Journal:  J Clin Endocrinol Metab       Date:  2018-03-01       Impact factor: 5.958

3.  Prevalence and impact of hyperandrogenemia in 1,218 women with polycystic ovary syndrome.

Authors:  Sarantis Livadas; Christos Pappas; Athanasios Karachalios; Evangelos Marinakis; Nikoleta Tolia; Maria Drakou; Philippos Kaldrymides; Dimitrios Panidis; Evanthia Diamanti-Kandarakis
Journal:  Endocrine       Date:  2014-04-22       Impact factor: 3.633

4.  Neuronal androgen receptor: Molecular gateway to polycystic ovary syndrome?

Authors:  David H Abbott
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-04       Impact factor: 11.205

5.  Rapid communication: A microRNA-132/212 pathway mediates GnRH activation of FSH expression.

Authors:  Jérôme Lannes; David L'Hôte; Ghislaine Garrel; Jean-Noël Laverrière; Joëlle Cohen-Tannoudji; Bruno Quérat
Journal:  Mol Endocrinol       Date:  2015-01-30

Review 6.  Ovarian and Extra-Ovarian Mediators in the Development of Polycystic Ovary Syndrome.

Authors:  Muraly Puttabyatappa; Vasantha Padmanabhan
Journal:  J Mol Endocrinol       Date:  2018-10-16       Impact factor: 5.098

Review 7.  CLINICAL PRACTICE. Polycystic Ovary Syndrome.

Authors:  Christopher R McCartney; John C Marshall
Journal:  N Engl J Med       Date:  2016-07-07       Impact factor: 91.245

8.  Developmental Programming: Prenatal and Postnatal Androgen Antagonist and Insulin Sensitizer Interventions Prevent Advancement of Puberty and Improve LH Surge Dynamics in Prenatal Testosterone-Treated Sheep.

Authors:  Vasantha Padmanabhan; Almudena Veiga-Lopez; Carol Herkimer; Bachir Abi Salloum; Jacob Moeller; Evan Beckett; Rohit Sreedharan
Journal:  Endocrinology       Date:  2015-04-28       Impact factor: 4.736

9.  Combined androgen excess and Western-style diet accelerates adipose tissue dysfunction in young adult, female nonhuman primates.

Authors:  Oleg Varlamov; Cecily V Bishop; Mithila Handu; Diana Takahashi; Sathya Srinivasan; Ashley White; Charles T Roberts
Journal:  Hum Reprod       Date:  2017-09-01       Impact factor: 6.918

10.  Prepubertal Development of GABAergic Transmission to Gonadotropin-Releasing Hormone (GnRH) Neurons and Postsynaptic Response Are Altered by Prenatal Androgenization.

Authors:  Tova Berg; Marina A Silveira; Suzanne M Moenter
Journal:  J Neurosci       Date:  2018-01-26       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.